Autopsy report · NCT04318327
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
Cause of deathFunding or business
“Business decision”
Life of this trial
- Registered 4 months before it started.
- Ran for about 4 years 9 months before it stopped.
- 96 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Multiple Myeloma
- Interventions
- PHE885
- Participants
- 96
- Sites
- 9
- Countries
- Australia, Israel, Singapore, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.